These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 21908576)

  • 1. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
    Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
    Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD4
    Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
    Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
    Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
    Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
    Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
    J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
    Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
    Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
    Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
    Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.
    Samimi M; Benlalam H; Aumond P; Gaboriaud P; Fradin D; Kervarrec T; Florenceau L; Vignard V; Blom A; Touzé A; Gervois N; Labarriere N
    Cell Immunol; 2019 Oct; 344():103961. PubMed ID: 31472938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Production of Merkel Cell Polyomavirus Oncogene Specific T Cells From Healthy Donors for Adoptive Transfer.
    Davies SI; Barrett J; Wong S; Chang MJ; Muranski PJ; Brownell I
    Front Immunol; 2020; 11():592721. PubMed ID: 33362774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
    Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
    Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
    Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
    Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
    J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV.
    Kumar A; Kantele A; Järvinen T; Chen T; Kavola H; Sadeghi M; Hedman K; Franssila R
    PLoS One; 2012; 7(9):e45773. PubMed ID: 23029236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence?
    Csoboz B; Rasheed K; Sveinbjørnsson B; Moens U
    APMIS; 2020 Feb; 128(2):104-120. PubMed ID: 31990105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended T-Cell Epitope Landscape in Merkel Cell Polyomavirus Large T and Small T Oncoproteins Identified Uniquely in Patients with Cancer.
    Hansen UK; Lyngaa R; Ibrani D; Church C; Verhaegen M; Dlugosz AA; Becker JC; Straten PT; Nghiem P; Hadrup SR
    J Invest Dermatol; 2022 Jan; 142(1):239-243.e13. PubMed ID: 34298058
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study.
    Miller DM; Shalhout SZ; Wright KM; Miller MA; Kaufman HL; Emerick KS; Reeder HT; Silk AW; Thakuria M
    Cancer; 2024 Aug; 130(15):2670-2682. PubMed ID: 38696121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.
    Paulson KG; Carter JJ; Johnson LG; Cahill KW; Iyer JG; Schrama D; Becker JC; Madeleine MM; Nghiem P; Galloway DA
    Cancer Res; 2010 Nov; 70(21):8388-97. PubMed ID: 20959478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.